검색어 : 통합검색[922]
총 7,642건 중 1,000건 출력
, 98/100 페이지
-
971
- Longevity, Senescence and the Genome. By Caleb E. Finch. University of Chicago Press, Chicago and London. 1994. 922 pages. Paperback. Price £39.95 xx and $51.75. ISBN 0 226 24889 5.
- Sang, James H.; ; (Genetical research, v.64, 1994, pp.217-218)
-
972
- A genre analysis of English and Spanish research paper abstracts in experimental social sciences
- Martı́ n, Pedro Martı́ n; Tel.: +34-922-633434/317649; fax: +34-922-317611; (English for specific purposes, v.22, 2003, pp.25-43)
-
973
- Book Review Diagnosis and Management of Pituitary Disorders (Contemporary Endocrinology.) Edited by Brooke Swearingen and Beverly M.K. Biller. 475 pp., illustrated. Totowa, NJ, Humana Press, 2008. $139. 978-1-58829-922-2
- Vance, Mary Lee; ; (The New England journal of medicine, v.360, 2009, pp.1684-1685)
-
974
- Poupault Christophe , À l’ombre des faisceaux : les voyages français dans l’Italie des chemises noires (1922-1943) , Rome, École française de Rome, « Histoire, archéologie, sciences sociales, 499 », 2014, 922 p., 40 € :
- Saintin, Alexandre; ; (Vingtième siècle, v.129, 2015, pp.XXII-XXII)
-
975
- Response to Comment on Boden et al. Insulin Regulates the Unfolded Protein Response in Human Adipose Tissue. Diabetes 2014;63:912–922
- Boden, Guenther; Cheung, Peter; Salehi, Sajad; Homko, Carol; Loveland-Jones, Catherine; Jayarajan, Senthil; Stein, T. Peter; Barrero, Carlos A.; Merali, Salim; Williams, Kevin Jon; Liu, Ming-Lin; Division of Endocrinology/Diabetes/Metabolism, Temple University School of Medicine, Philadelphia, PA; Division of Endocrinology/Diabetes/Metabolism, Temple University School of Medicine, Philadelphia, PA; Division of Endocrinology/Diabetes/Metabolism, Temple University School of Medicine, Philadelphia, PA; Division of Endocrinology/Diabetes/Metabolism, Temple University School of Medicine, Philadelphia, PA; Department of Surgery, Temple University School of Medicine, Philadelphia, PA; Department of Surgery, Temple University School of Medicine, Philadelphia, PA; Department of Surgery, University of Medicine and Dentistry New Jersey, Stratford, NJ; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA; Clinical Research Center, Temple University School of Medicine, Philadelphia, PA; Clinical Research Center, Temple University School of Medicine, Philadelphia, PA; (Diabetes, v.63, 2014, pp.e2-e2)
-
976
- Dr. John P. Buckley (←) Guest of Honor at the Annual Banquet of the Chicago Dental Society, January 19, J922, Drake Hotel
- ; ; (The journal of the national dental association, v.9, 1922, pp.ii)
-
977
- Characteristics and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome Switching to Ravulizumab from Eculizumab: A Global Registry Analysis : SA-PO922
- Schaefer, Franz S.; Al-Dakkak, Imad; Anokhina, Ekaterina; Cohen, David J.; Greenbaum, Larry A.; Ariceta, Marí a; Heidelberg University Hospital, Heidelberg, Germany; ; Alexion, AstraZeneca Rare Disease, Boston, MA; ; Alexion, AstraZeneca Rare Disease, Boston, MA; ; Columbia University Medical Center, New York, NY; ; Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA; ; Vall d'Hebron Hospital, Barcelona, Spain.; (Journal of the American Society of Nephrology : JASN, v.34, 2023, pp.987-987)
-
978
- 61 Evaluation of the synthetic heat shock protein 90 inhibitors NVP-AUY922 and NVP-HSP990 in human prostate cancer tissue
- Centenera, M.M.; Treloar, J.L.; Hanson, A.; Sutherland, P.; Tilley, W.D.; Butler, L.M.; ; (EJC supplements, v.8, 2010, pp.28)
-
979
- Abstract 590: Antiproliferative effects and signaling profiles of the novel HSP90 inhibitor NVP-AUY922 in non-small cell lung cancer
- Ueno, Tsuyoshi; Toyooka, Shinichi; Tsukuda, Kazunori; Munenori, Takaoka; Soh, Junichi; Maki, Yuho; Muraoka, Takayuki; Tanaka, Norimitsu; Asano, Hiroaki; Yamane, Masaomi; Oto, Takahiro; Kiura, Katsuyuki; Naomoto, Yoshio; Miyoshi, Shinichiro; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.71, 2011, pp.590-590)
-
980
- Phase I study of the HSP90 inhibitor AUY922 in combination with capecitabine as treatment for patients with advanced solid tumors.
- Bendell, Johanna C.; Hart, Lowell L.; Pant, Shubham; Infante, Jeffrey R.; Jones, Suzanne Fields; Mohyuddin, Adil; Murphy, Patrick; Patton, Jeffrey; Penley, William Charles; Thompson, Dana Shelton; Burris, Howard A.; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Florida Cancer Specialists/SCRI, Ft. Myers, FL; Stephenson Cancer Center/SCRI, Oklahoma City, OK; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Sarah Cannon Research Institute, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.31, 2013, pp.475-475)
QUICK MENU
